Dublin, April 14, 2021 (GLOBE NEWSWIRE) — The “Global Clinical Trials Connect 2021” convention has been added to ResearchAndMarkets.com’s providing.
The 4th Annual Global Clinical Trials Connect 2021 will present a platform to debate on the futuristic developments in scientific trials and scientific analysis.
This multidisciplinary program entails broad participation of individuals from scientific trials neighborhood from across the globe who’re targeted on studying extra about scientific analysis, scientific trials planning and administration.
The Pharma and Bio-Tech corporations are persistently evolving and new scientific research, applied sciences and developments in care and coverings have augmented the effectivity and on the similar time, the complexity of scientific trials has elevated, with exams being carried out in a extremely structured and carefully coordinated method. It is excessive time that we glance into modern methods, new applied sciences, efficient and high quality collaborations to deal with these points, which might cater to the wants of the affected person and the trade.
This convention intends to give attention to the worldwide well being and scientific trials all over the world. Bioethics, rules, affected person recruitment, web site choice, real-world information, information integration & Strategy, outsourcing, vendor administration, high quality (QbD) in Trial Conduct, risk-based monitoring, scientific auditing & monetary planning and different vital matters that play a key position in scientific trials will likely be addressed together with modern periods on new applied sciences, efficient and high quality collaborations.
This program will definitely educate well being care scientists on trial design, operations, organizing trials, analysis computing, regulatory elements, report on scientific trials and achieve a greater information of the implications of scientific trials in prevention, prognosis, scientific trial-related ethics and illness therapies.
The Virtual summit will facilitate a useful networking alternatives with Decision makers and Industry consultants, specializing in actual case research and insightful shows. Bringing in Exciting options like Q&A Sessions with trade consultants, Networking Video Chat, Polling, Raise Hand, Virtual Exhibitor cubicles with ready room/tables and digital chat, Peer to Peer join at Social Lounge, Handout Bags and extra giving alternative to develop and increase your networking all through the occasion
Key Highlights
- Patient Recruitment and Site choice
- Innovative trial designs
- Partnership & Collaboration – Sponsors, CROs, Sites and External Vendors
- Patient centric scientific trials
- Making Patient Engagement a Reality
- New improvements in Patient Recruitment planning and execution on a scientific trial
- Outsourcing methods and fashions
- Electronic Clinical Outcome Assessment and Electronic Patient Reported Outcome
- Streamlined IRT growth course of
- Pharmacovigilance & Clinical Trials
- Post-Clinical Trial closed communities
- How to future proof your scientific operations
- Implementing Risk Based Monitoring
- Streamlining R&D and decrease prices in scientific trials
- Adaptive Trial Model
- Clinical Trial Auditing
- Real World Clinical Trial Strategies
- Data Quality & Technology
- Clinical Data Strategy & Analytics
- Electronic Data Capture (EDC) Systems
- Clinical Technology and Driving Innovation
- M-Health, Wearable and Consumer Technology
- Big-Data, IoT and Artificial Intelligence in Clinical trials
- Blockchain know-how for enhancing scientific analysis high quality
Who Should Attend:
This occasion is designed for senior-level attendees from numerous corporations together with Pharmaceutical, Bio-Tech, Bio-Pharma, CRO’s, Investigative Sites, Solution supplier and Government establishments.
Attendees embrace VPs, GMs, Directors, Heads and Managers of
- Clinical Trials
- Clinical Study Management
- Clinical Operations
- Clinical Research
- Patient Organizations
- Patient Recruitment
- Outsourcing
- Vendor Management
- Site Management
- Site Monitoring
- Clinical Pharmacology
- IT
- Clinical Data Management
- EDC
- Clinical/Digital Innovation
- Clinical Design/Protocol design/ Strategy makers
- Clinical Research Sites
- CROs and CMOs
- Hospitals/ Associations
- Regulatory affairs
Speakers
Daniel De Schryver
Patient Engagement & Advocacy Lead, EMEA
Janssen Pharmaceutical
Catherine O’Connor
Director, Global Clinical Research
Gilead Sciences
Adama Ibrahim
Director, Digital Solutions (Global Drug Development)
Novartis
Bodo Lutz
Global Risk Management, Data Integrity, and Quality Assurance
Novartis
Ana Herradon Virseda
Associate Director, Monitoring Manager
Bristol-Myers Squibb
Maria Kuthning
Clinical Program Leader
Sobi – Swedish Orphan Biovitrum AB (publ)
Pawel Wojcik
Associate Director Study Management (Clinical Operations, R&D Oncology)
Astrazeneca
Maria Palombini
Leader, Healthcare Life Sciences Practice
IEEE Standards Association
Tamzin Blagbrough
Sourcing guide
Eli Lilly
Sol Yates
Associate Director Regulatory Affairs Development
Grunenthal
Veronique Freund
Head of Clinical External Parties Quality Management
Sanofi
Edyta Zbirog-Lukawska
Central Europe Quality And Compliance Adviser (Affiliate Process and Training Adviser)
Roche
Lucy Hampshire
Senior Director, Medicines Quality
Eli Lilly and Company
Karen Hue
Senior GxP Consultant
30 TECHNOLOGY
Devaki Nair
Clinical Lead for Clinical Biochemistry and HOD – Director SAS Centre for Cardiac Biomarkers
NHS
Ellen Van Vijnckt
Head Start-Up & Admin Team Country Clinical Operations
Roche
Vladimir Anisimov
Principal Data Scientist | Data Science | Center for Design & Analysis
Amgen
Nancy Meyerson-Hess
Chief Compliance and Regulatory Officer
eMQT
Kylie Gyertson
Head of Cancer Clinical Trials Unit
UCLH
Tim Cave
SaySo Medical CEO & Founder
SaySo Medical
Marc Ditmarsch
VP Clinical & Operations
NewAmsterdam Pharma
Gareth Powell
Business Development Officer
NIHR
For extra details about this convention go to https://www.researchandmarkets.com/r/5q5mpe
